SWK Holdings CorpSWKHEarnings & Financial Report
SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.
Revenue
$10.1M
Gross Profit
N/A
Operating Profit
$4.6M
Net Profit
$3.5M
Gross Margin
N/A
Operating Margin
46.1%
Net Margin
35.2%
YoY Growth
-7.3%
EPS
$0.29
SWK Holdings Corp Q2 FY2025 Financial Summary
SWK Holdings Corp reported revenue of $10.1M (down 7.3% YoY) for Q2 FY2025, with a net profit of $3.5M (down 3.9% YoY) (35.2% margin).
Key Financial Metrics
| Total Revenue | $10.1M |
|---|---|
| Net Profit | $3.5M |
| Gross Margin | N/A |
| Operating Margin | 46.1% |
| Report Period | Q2 FY2025 |
SWK Holdings Corp Annual Revenue by Year
SWK Holdings Corp annual revenue history includes year-by-year totals (for example, 2025 revenue was $41.5M).
| Year | Annual Revenue |
|---|---|
| 2025 | $41.5M |
| 2024 | $45.0M |
| 2023 | $29.1M |
| 2022 | $41.5M |
SWK Holdings Corp Quarterly Revenue & Net Profit History
SWK Holdings Corp results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $8.7M | -29.7% | $-19.4M | N/A |
| Q3 FY2025 | $10.9M | +4.5% | $8.8M | 80.7% |
| Q2 FY2025 | $10.1M | -7.3% | $3.5M | 35.2% |
| Q1 FY2025 | $11.8M | +4.2% | $4.5M | 38.4% |
| Q4 FY2024 | $12.4M | +25.0% | $5.9M | 47.5% |
| Q3 FY2024 | $10.4M | +16.2% | $3.5M | 33.3% |
| Q2 FY2024 | $10.8M | +14.2% | $3.7M | 33.9% |
| Q1 FY2024 | $11.4M | +20.7% | $468.0K | 4.1% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.4M | $10.8M | $10.4M | $12.4M | $11.8M | $10.1M | $10.9M | $8.7M |
| YoY Growth | 20.7% | 14.2% | 16.2% | 25.0% | 4.2% | -7.3% | 4.5% | -29.7% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $322.0M | $321.0M | $321.3M | $332.2M | $331.3M | $285.7M | $289.4M | $272.4M |
| Liabilities | $42.1M | $38.2M | $37.8M | $43.5M | $38.6M | $39.2M | $35.2M | $37.3M |
| Equity | $279.9M | $282.8M | $283.4M | $288.7M | $292.7M | $246.5M | $254.2M | $235.1M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $4.4M | $5.4M | $6.3M | $23.0M | $8.3M | $7.8M | $906000 | $27.3M |